stride study semaglutide 🔴The trial! 👟⤵️ 🔹The STRIDE trial demonstrated that significantly improves function, symptoms, and health-related QoL in patients with symptomatic #cvPAD and T2DM STRIDE is a first step

The 2024 dual-therapy study found no increase in GI side effects when sermorelin was added to semaglutide, suggesting the peptides don't compound each other's tolerability issues

Tirzepatide appears to activate GIPR stronger than GLP1R in cell systems with high levels of both gene expressions [20]

Remove air bubbles

Nat Rev Endocrinol 9 , 366376 (2013)

Your body needs consistent energy and micronutrients to support a functioning metabolism, immune system, bone strength, muscle maintenance, cognitive function, and heart health

And if a patient meets their goalsloses weight, improves blood sugar, blood pressure, or cholesterolwe may even de-escalate therapy by lowering the semaglutide dose or switching to liraglutide to prevent excess weight loss, which can come at the expense of muscle mass. Overall, switching works best when its intentional and coordinated with your physician